Tristel is pleased to announce the appointment of Christopher (“Chris”) Lee as Chief Executive Officer, effective from 1 August 2026.
Chris joins Tristel with over 35 years of experience in the medical technology and healthcare sector, bringing a strong track record in leadership, commercial strategy and international growth.
Most recently, Chris served as CEO of Summit Medical Ltd, where he successfully led the strategic development of the business and supported its expansion across international markets. Earlier in his career, he held senior roles at organisations including Venner Medical International, Teleflex Incorporated and LMA International.
Chris’s global experience, particularly across Europe and the United States, will be instrumental as Tristel continues to build on its strong international platform and drive further growth.
Chris commented:
“I am delighted to join Tristel as Chief Executive Officer and to build on the Company’s leading position in infection prevention globally. I look forward to working with the team to deliver continued growth and innovation.”
Bruno Holthof, Chair of Tristel, said:
“We are delighted to welcome Chris to Tristel. His industry experience and insight make him well placed to lead the business through its next phase of growth and international expansion.”
Read in Full: Appointment of CEO – 17 June 2026
